<DOC>
	<DOCNO>NCT00656474</DOCNO>
	<brief_summary>Study intend evaluate safety efficacy parameter patient treat GLYC-101 gel placebo laser ablation .</brief_summary>
	<brief_title>Efficacy Study GLYC-101 Evaluate Outcomes After Post-laser Ablation</brief_title>
	<detailed_description>The propose pilot-study document feasibility , safety efficacy topically apply Glucoprime gel ( GLYC-101 gel 1.0 % ) promoting wound heal healthy volunteer subject undergoing retro-auricular Carbon Dioxide Laser Skin Resurfacing ( CO2 LSR ) . The study observe effect topical agent course 1 month follow treatment . preparation study GLYC-101-1b ( Double-blind , randomize , placebo-controlled Phase 2 Pilot Study investigate safety efficacy 1.0 % topically apply GLYC 101 compare placebo , patient undergo Carbon Dioxide Laser Skin Resurfacing ) .</detailed_description>
	<criteria>Subjects meet follow criterion consider admission study : Patients give informed consent retroauricular laser ablation 25 55 year old . Retroauricular area free irritation , scar dermatologic condition might interfere study . Willing able participate study follow study direction . Able read , understand sign consent form . Pregnant , nursing , plan pregnancy course study , determine interview urine pregnancy test . Systemic cutaneous disease may interfere study result . Presence irritation dermatologic skin condition retroauricular area . Known allergy material within test formulation . Systemic cutaneous therapy medication impact wound heal ( steroid , immune modulators , immune suppressant ) .</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>burn wound</keyword>
	<keyword>wound healing</keyword>
</DOC>